Failure rates in drug discovery and development: will we ever get any better?
Posted in Archive
| Tagged Academic, ADME / Tox, AI / data analytics / healthtech / informatics, Analysis, Automation / robotics, Business, Cell therapy, Chemical engineering, Chemistry, Clinical trials, Combinatorial chemistry, Drug development, Drug discovery, Gene therapy, Genomics, Lead discovery, Lead optimisation, Patent Law, Pharmacology, Preclinical, Screening, Stem cells, Therapeutics
